AEON Biopharma, Inc.
AEONNYSECIK 1837607HealthcareFiscal year ends Dec 31
Reports and events: 145 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000071 |
| 2026-09-3008:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000064 |
| 2026-08-1216:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001837607-26-000062 |
| 2026-08-1216:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000061 |
| 2026-08-0316:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000057 |
| 2026-07-2316:01 ET | 8-K | 8.01 Other events | 0001837607-26-000055 |
| 2026-07-1516:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000052 |
| 2026-07-0910:57 ET | S-1/A | Registration statement, amended | 0001104659-26-082167 |
| 2026-07-0817:26 ET | S-1 | Registration statement | 0001104659-26-081860 |
| 2026-06-1716:05 ET | 8-K | 5.07 Shareholder vote results | 0001837607-26-000046 |
| 2026-05-1416:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000043 |
| 2026-05-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001837607-26-000042 |
| 2026-05-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-26-000041 |
| 2026-04-2917:18 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001837607-26-000033 |
| 2026-04-0316:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001837607-26-000025 |
| 2026-03-3017:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001837607-26-000019 |
| 2026-03-3017:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-26-000018 |
| 2026-03-0916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001837607-26-000009 |
| 2026-01-2921:24 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-009802 |
| 2026-01-2921:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-009785 |
| 2026-01-2116:06 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000005 |
| 2026-01-1209:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000002 |
| 2025-12-2916:05 ET | DEF 14A | Proxy statementPeriod 2025-12-29 | 0001837607-25-000104 |
| 2025-12-1516:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000092 |
| 2025-12-0409:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000088 |
| 2025-11-1408:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001837607-25-000085 |
| 2025-11-1408:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000084 |
| 2025-11-1308:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001837607-25-000072 |
| 2025-09-0817:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000068 |
| 2025-08-1216:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001837607-25-000066 |
| 2025-08-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000065 |
| 2025-06-1316:05 ET | 8-K | 5.07 Shareholder vote results | 0001837607-25-000059 |
| 2025-06-1116:06 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-03-31 | 0001104659-25-058535 |
| 2025-06-1116:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001104659-25-058531 |
| 2025-05-2016:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000055 |
| 2025-05-1416:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001837607-25-000050 |
| 2025-05-1416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000049 |
| 2025-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001837607-25-000035 |
| 2025-04-2516:06 ET | 8-K | 3.01 Delisting notice | 0001837607-25-000032 |
| 2025-04-2116:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001837607-25-000030 |
| 2025-04-0816:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001837607-25-000027 |
| 2025-03-2716:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000025 |
| 2025-03-2416:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001837607-25-000022 |
| 2025-03-2416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000021 |
| 2025-03-1006:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000015 |
| 2025-03-0716:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-021722 |
| 2025-02-2414:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000013 |
| 2025-02-0716:07 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001837607-25-000010 |
| 2025-01-2316:45 ET | DEF 14A | Proxy statementPeriod 2025-02-24 | 0001837607-25-000007 |
| 2025-01-2216:02 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-005235 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:43 ET. Listed shows no prices and gives no investment advice.